Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:2565:343-359.
doi: 10.1007/978-1-0716-2671-9_23.

Quantification of Chromogranin A and Its Fragments in Biological Fluids

Flavio Curnis  1 , Barbara Colombo  2 , Angelo Corti  3
Affiliations

Quantification of Chromogranin A and Its Fragments in Biological Fluids

Flavio Curnis et al. Methods Mol Biol. 2023.

Abstract

Human chromogranin A (CgA), a 439-residue long neurosecretory protein, can serve as a circulating biomarker for a wide range of neuroendocrine tumors. Increased levels of immunoreactive CgA are also present in the blood of patients with cardiovascular, gastrointestinal, or inflammatory diseases with, in certain cases, important diagnostic and prognostic implications. A growing body of evidence suggest that CgA and various CgA-derived fragments have complex roles in the regulation of cardiovascular system, metabolism, innate immunity, angiogenesis, and tissue repair, sometime with opposite biological effects. For example, while full-length CgA (CgA1-439) inhibits angiogenesis, the CgA1-373 fragment, at certain doses, is proangiogenic. Thus, the selective quantification of CgA and its fragments in the blood of patients (and in other biological fluids) is of great experimental and clinical interest. Here, we describe methods to produce CgA1-439 and CgA1-373 and to develop ELISAs capable of detecting these polypeptides in a very selective manner. The same approach can be used, in principle, also for developing assays for other fragments.

Keywords: Antibody; Assay; CgA1-373; Chromogranin A; ELISA; Expression; Purification.

PubMed Disclaimer

References

    1. Banks P, Helle KB (1965) The release of protein from the stimulated adrenal medulla. Biochem J 97:40C–41C - DOI
    1. Deftos LJ (1991) Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 12(2):181–187 - DOI
    1. Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Oberg K (1997) Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 8(7):685–690 - DOI
    1. Taupenot L, Harper KL, O’Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348(12):1134–1149 - DOI
    1. Helle KB, Corti A, Metz-Boutigue MH, Tota B (2007) The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64(22):2863–2886. https://doi.org/10.1007/s00018-007-7254-0 - DOI - PubMed

Publication types

LinkOut - more resources